Legal & General Group PLC Applied Genetic Technologies Corp Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$3.62 - $5.23 $16,800 - $24,272
-4,641 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$3.94 - $8.19 $10,169 - $21,138
2,581 Added 125.29%
4,641 $24,000
Q3 2020

Nov 13, 2020
SELL
$4.38 - $6.43 $3,906 - $5,735
-892 Reduced 30.22%
2,060 $10,000
Q2 2020

Aug 14, 2020
BUY
$3.0 - $6.9 $8,856 - $20,368
2,952 New
2,952 $16,000

About APPLIED GENETIC TECHNOLOGIES CORP

AGTC Quotes by TradingView
  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email